Repair of Thoracoabdominal Aortic Aneurysms

Description

The primary objective of the clinical investigation is to assess the use of the Medtronic Valiant Thoracoabdominal Stent Graft System to repair thoracoabdominal aortic aneurysms in patients having appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device. Additionally, the study will assess technical success and treatment success at each follow-up interval.

Conditions

Thoracoabdominal Aneurysm

Study Overview

Study Details

Study overview

The primary objective of the clinical investigation is to assess the use of the Medtronic Valiant Thoracoabdominal Stent Graft System to repair thoracoabdominal aortic aneurysms in patients having appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device. Additionally, the study will assess technical success and treatment success at each follow-up interval.

Endograft Repair of Thoracoabdominal Aortic Aneurysms (TAAA)

Repair of Thoracoabdominal Aortic Aneurysms

Condition
Thoracoabdominal Aneurysm
Intervention / Treatment

-

Contacts and Locations

Cincinnati

The Christ Hospital, Cincinnati, Ohio, United States, 45219

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. A patient may be entered into the study if the patient has at least one of the following:
  • 1. an aneurysm with a maximum diameter of \> 5.5 cm or 2 times the normal diameter just proximal to the aneurysm using orthogonal (i.e., perpendicular to the centerline) measurements
  • 2. aneurysm with a history of growth \> 0.5 cm in 6 months
  • 3. saccular aneurysm deemed at significant risk for rupture
  • 4. symptomatic aneurysm greater than 4.5 cm
  • 2. Axillary or brachial and iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices or accessories, with or without use of a surgical conduit.
  • 3. Proximal landing zone for the thoracic bifurcation stent graft that has:
  • 1. ≥ 2.5 cm of nonaneurysmal aortic segment including previously placed graft material (neck) distal to the left subclavian artery (LSA) diameter in the range of 26-42 mm.
  • 2. adequate distance from the celiac artery, in order to accommodate cannulation from the antegrade access point when considering the total deployed length of the thoracic bifurcation and visceral manifold.
  • 4. Minimum branch vessel diameter ≥ 5 mm.
  • 5. Iliac artery or aortic distal fixation site, including both native tissue and previously placed graft, greater than or equal to 15 mm in length and diameter in the range of 8 - 25 mm.
  • 6. Patient is ≥ 18 years of age.
  • 7. Patient has a life expectancy \> 1 year.
  • 1. Patient is a good candidate for and elects open surgical repair.
  • 2. Patient can be treated in accordance with the instructions for use with a legally marketed endovascular prosthesis.
  • 3. Patient is eligible for enrollment in a manufacturer-sponsored IDE at the investigational site.
  • 4. Patient is unwilling to comply with the follow-up schedule.
  • 5. Patient is unable or refuses to give informed consent.
  • 6. Urgent or emergent presentation.
  • 7. Patient is pregnant or breastfeeding.
  • 8. Patient has a contained rupture.
  • 9. Patient has a ruptured aneurysm.
  • 10. Patient has a dissection in the treated portion of the aorta.
  • 11. Obstructive stenting of any or all of the visceral vessels.
  • 12. Poor performance status including 2 major system failures (cardiovascular, renal, hepatobiliary, neuromuscular).

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Christ Hospital,

Geoffrey Answini, MD, PRINCIPAL_INVESTIGATOR, The Christ Hospital

Study Record Dates

2029-05